Concepedia

Yuki Kurahashi

YK

Statistics

Publications

6

Citations

126

H-Index

6

Active since

2020

Affiliations

Saga University(Current)

Kumamoto University

Tokyo University of Pharmacy and Life Sciences

Yuki Kurahashi is an author at Saga University specializing in medicine, molecular oncology, and epigenetics.

ORCID

Publications per year

2020–2023

6

Publications

6

Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100

Tatsuro Watanabe, Satoshi Yamashita, Hiroshi Ureshino et al. · Blood · 2020 · 49 citations · Full text

, , +14

Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL

Yuki Kurahashi, Tatsuro Watanabe, Yuta Yamamoto et al. · Blood Advances · 2022 · 20 citations · Full text

, , +17

Targeting DNMT1 by demethylating agent OR-2100 increases tyrosine kinase inhibitors-sensitivity and depletes leukemic stem cells in chronic myeloid leukemia

Kazuharu Kamachi, Hiroshi Ureshino, Tatsuro Watanabe et al. · Cancer Letters · 2021 · 16 citations · Full text

, , +17

Adult T‐cell leukemia‐lymphoma acquires resistance to <scp>DNA</scp> demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism

Nao Yoshida‐Sakai, Tatsuro Watanabe, Yuta Yamamoto et al. · International Journal of Cancer · 2021 · 15 citations · Full text

, , +15

Silylation of Deoxynucleotide Analog Yields an Orally Available Drug with Antileukemia Effects

Hiroshi Ureshino, Yuki Kurahashi, Tatsuro Watanabe et al. · Molecular Cancer Therapeutics · 2021 · 13 citations · Full text

, , +17

1–5 of 6